Charles Schwab Investment Management Inc. cut its holdings in Arteris, Inc. (NASDAQ:AIP – Free Report) by 4.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 75,392 shares of the company’s stock after selling 3,679 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.19% of Arteris worth $582,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also added to or reduced their stakes in AIP. US Bancorp DE acquired a new stake in shares of Arteris in the 3rd quarter valued at $34,000. The Manufacturers Life Insurance Company acquired a new position in Arteris during the 2nd quarter valued at about $86,000. Algert Global LLC acquired a new position in shares of Arteris in the 2nd quarter valued at $115,000. Rhumbline Advisers boosted its position in shares of Arteris by 2,182.8% in the 2nd quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock worth $239,000 after purchasing an additional 30,428 shares during the last quarter. Finally, CloudAlpha Capital Management Limited Hong Kong acquired a new stake in shares of Arteris during the second quarter worth $554,000. Institutional investors and hedge funds own 64.36% of the company’s stock.
Arteris Stock Performance
Shares of AIP opened at $9.34 on Thursday. Arteris, Inc. has a twelve month low of $4.83 and a twelve month high of $10.60. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. The firm’s 50 day moving average price is $8.10 and its two-hundred day moving average price is $7.85. The firm has a market cap of $375.25 million, a P/E ratio of -9.73 and a beta of 1.25.
Analyst Ratings Changes
Get Our Latest Stock Report on Arteris
Insider Buying and Selling
In other Arteris news, CFO Nicholas B. Hawkins sold 5,000 shares of the firm’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $7.35, for a total transaction of $36,750.00. Following the completion of the sale, the chief financial officer now owns 219,659 shares of the company’s stock, valued at $1,614,493.65. This trade represents a 2.23 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Paul L. Alpern sold 3,615 shares of Arteris stock in a transaction on Friday, October 4th. The stock was sold at an average price of $7.13, for a total transaction of $25,774.95. Following the transaction, the vice president now directly owns 68,084 shares of the company’s stock, valued at approximately $485,438.92. This trade represents a 5.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 92,717 shares of company stock worth $791,369. 33.70% of the stock is owned by corporate insiders.
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Recommended Stories
- Five stocks we like better than Arteris
- What is a Low P/E Ratio and What Does it Tell Investors?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What is a Secondary Public Offering? What Investors Need to Know
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What is the Australian Securities Exchange (ASX)
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.